CCDC66

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, CCDC66 mutation is significantly associated with the RNA expression of many other genes, with 1,657 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CCDC66-associated genes across cancer lineages are TRAJ5, GAPDHP17, and TMEM225. Each is linked with CCDC66 in more than 2 cancer types. Because this analysis shows association rather than direction, both CCDC66-to-partner and partner-to-CCDC66 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, TRAJ5 grouped by CCDC66-low versus CCDC66-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CCDC66→partner) and Y-score (partner→CCDC66) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCATRAJ5 →+0.676+3.291.002.00833
LGGGAPDHP17 →+0.039+7.977<.001.00732
READTMEM225 →+0.114+5.039<.001.00832
READIGHD5-12 →+1.742+5.421<.001.00532
LUADRNU6-502P →+0.427+5.631<.001.00432
LUADGAGE2E →+0.627+6.197<.001.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 1,657 associations by consensus.

TRAJ5 by CCDC66 expression — BLCA

Box plot of TRAJ5 in CCDC66-low vs CCDC66-high samples in BLCA.

Explore this box plot interactively →

Exploration